Granules India completes acquisition of Senn Chemicals
Strengthening capabilities in Peptide Therapeutics and CDMO services
Strengthening capabilities in Peptide Therapeutics and CDMO services
AstraZeneca Pharma India discontinues manufacturing of Imdur
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
This e-commerce platform is launched as a hyperlocal model
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
Subscribe To Our Newsletter & Stay Updated